Part of purified human plasma kallikrein removed together with a remaining IgG fraction - Immunoblot experiments and functional tests

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 62, Issue 1, 2002, Pages 21-24

  Briseid, K ^a   Johannesen, S ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

IgG; Plasma kallikrein

Indexed keywords

AMIDASE; BENZOYLPROLYLPHENYLALANYLARGININE; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; CHROMOGENIC SUBSTRATE; DEXTRO PROLYLPHENYLALANYLARGININE 4 NITROANILIDE; GLUTAMYLPROLYLARGININE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; KALLIKREIN; MONOCLONAL ANTIBODY; N BENZOYLISOLEUCYL GAMMA GLUTAMYLGLYCYLARGININE 4 NITROANILIDE; PREKALLIKREIN; PYROGLUTAMYLPROLYLARGININE 4 NITROANILIDE; REAGENT; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SUBSTRATE; FUNCTION TEST; HUMAN; IMMUNOBLOTTING; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; STORAGE;

AMIDOHYDROLASES; BLOTTING, WESTERN; CHROMATOGRAPHY, GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FACTOR XI; FACTOR XII; HUMANS; IMMUNOGLOBULIN G; KALLIKREINS;

EID: 0036185235     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655102753517163     Document Type: Article

References (12)

1. Significance of IgG for the activity of factor XII measured in human plasma
2. Part of prekallikrein removed from human plasma together with IgG-immunoblot experiments and functional tests
3. Removal of IgG from normal plasma and plasma from untreated patients with active Crohn's disease - Effect on levels of contact factors
4. Recurrent thrombosis in a young woman with a circulating anti-coagulant directed against factors XI and XII
5. Acquired antibody to FXI in a patient with congenital factor XI deficiency
6. a
7. An autoantibody to human plasma prekallikrein blocks activation of the contact system
8. Human plasma kallikrein - A rapid purification method with high yield
9. Determination of prekallikrein in human plasma: Optimal conditions for activating prekallikrein
10. Centrifugal analysis for plasma kallikrein activity, with use of the chromogenic substrate S-2302
11. a
12. Enzymes of the contact phase of blood coagulation: Kinetics with various chromogenic substrates and a two-substrate assay for the joint estimatian of plasma prekallikrein and factor XI